Definition: Drugs are substances used to promote and maintain health.
Misuse of Drugs: Often misused for relief from tension or escapism from social/family problems.
Provide a sense of well-being.
Act as sedatives.
Definition: A compulsion to take drugs for desired effects or to prevent unpleasant withdrawal symptoms.
Drugs of Dependence:
Cause psychological dependence (soft drugs)
Cause psychological and physical dependence (hard drugs).
Hard Drugs: Cause severe physical dependence (e.g., morphine, heroin, alcohol).
Soft Drugs: Do not cause physical dependence but cause psychological dependence (e.g., cannabis, LSD).
Inhalation: Nicotine, ganja.
Ingestion: Opium, barbiturates.
Snorting: Cocaine (fastest route).
Skin Popping: Subcutaneous injections (heroin, morphine).
Mainlining: IV injections (morphine, pethidine).
Morphine Type:
Strong desire to continue use.
Tolerance developed.
Withdrawal symptoms within 8 hours, subsiding by 2-3 days.
Barbiturate Type:
Strong desire, high tolerance.
Maximum withdrawal symptoms in 2-3 days, subsiding slowly.
Cocaine Type:
Overpowering desire to continue.
Rapid tolerance development with no withdrawal symptoms.
Cannabis Type:
Psychic dependence.
No withdrawal symptoms, no tolerance.
Amphetamine Type:
Persistent need to continue.
Tolerance development, potential for hyper-excitement and psychosis.
Amphetamine
Caffeine
Cannabis
Cocaine
LSD
Mescaline
Tobacco
Morphine
Pethidine
Heroin
Methadone
Alcohol
Barbiturates
Codeine
Benzodiazepines
Phencyclidine (Angel dust/Peaspill)
Meprobamate
Methaqualone
Mandrax: Methaqualone + Diphenhydramine
Narcotics and depressants: cause both psychological and physical dependence.
Stimulants and hallucinogens: cause psychological dependence.
Drugs notorious for causing dependence: morphine, pethidine, heroin, methadone, alcohol.
Tolerance
Withdrawal symptoms
Dependence syndrome
Harmful effects (mental and physical)
Common Withdrawal Syndrome:
Hangover
Symptoms of Withdrawal Syndrome:
Delirium tremens
Alcoholic seizures
Hallucinosis
Laboratory Findings:
GGT (gamma-glutamyl-transferase) raised to 40 IU/L in 80% of alcohol-dependent individuals.
Alpha Alcoholism: No psychological or physical dependence.
Beta Alcoholism: No psychological or physical dependence, but cirrhosis develops.
Gamma Alcoholism: Physical and behavioral complications.
Delta Alcoholism (French): Strong psychological or physical dependence due to long-term use.
Epsilon Alcoholism: Dipsomania develops leading to potential lethal drinking.
Medications:
Chlordiazepoxide (80–200 mg/day)
Diazepam (40–80 mg/day)
Deterrent Agents (Alcohol Sensitizing Drugs):
Disulfiram
Calcium carbimide
Metronidazole
Nitrafural
Methylthiotetrazole
Anti-craving Agents:
Acamprosate
Naltrexone
Fluoxetine (Clonidine)
Common Dermatological Manifestation: 'Railroad tracks' (track marks).
Withdrawal Symptoms Start: 12-24 hours after last use.
Nausea, vomiting, abdominal cramps
Diarrhea, yawning
Lacrimation, rhinorrhea
Pupillary dilatation, insomnia
Tachycardia, muscle cramps
Piloerection (goosebumps)
Elevated BP, temperature, respiratory rate
Withdrawal syndrome severity is worse in heroin than morphine.
Naloxone and Naltrexone
Methadone,
Clonidine, Levo-alpha-acetylmethadol (LAAM), Propoxyphene, Diphenoxylate, Buprenorphine, Lofexidine
Methadone
Alternate options: Buprenorphine, LAAM
Dependence Type:
Mild physical but strong psychic dependence.
Tolerance:
May develop; cocaine addicts can tolerate up to 10 gm/day.
Withdrawal Symptoms:
Minimal or nil withdrawal symptoms but strong psychic dependence persists.
Gender Factors:
Females are 3.3 times more likely to become dependent than males.
Bromocriptine
Amantadine
Desipramine or Imipramine
Psychotherapy: Most important aspect of treatment.
Dependence and Withdrawal: Psychic dependence without withdrawal syndrome; no tolerance developed.
Effects: Starts within a few hours, lasting for 4-5 days.
Amotivational Syndrome: Characterized by lethargy and lack of interest in daily activities.
Treatment: Psychotherapy and symptomatic treatment.
Dependence: Marked physical and psychological dependence; rapid tolerance development.
Withdrawal Symptoms: Severe symptoms in those taking >600-800 mg/day, including:
Tremors
Hypertension
Seizures
Psychosis resembling delirium tremens.
Progression: Symptoms worsen by about 72 hours; coma and death possible.
Treatment: Conservative management; pentobarbital substitution in forensic medicine.
Origins: Derived from ephedrine; CNS stimulant.
Usage: Can be taken by snorting, smoking, ingestion, or intravenous administration.
Abusers: Common among students and athletes seeking to combat sleep and fatigue.
Symptoms: Similar to cocaine abuse.
Acute Intoxication includes:
Cardiovascular Symptoms: Tachycardia, hypertension, cardiac failure.
CNS Symptoms: Anxiety, seizures, euphoria, insomnia.
Chronic Use: Paranoid hallucinatory syndrome similar to paranoid schizophrenia; high tolerance; severe withdrawal symptoms.
Methamphetamine: Superior to amphetamine and included in athlete doping tests.
Derivatives: 3-4 Methylene-dioxy-methamphetamine (MDMA), 3-4 Methylene-dioxyamphetamine (MDA), 3-4 Methylene-dioxyethyl-amphetamine (MDE or MDEA).
Classification: Known as hug drug, club drug, or rave drug.
Interactions: MDMA + Marijuana referred to as 'love boat'.
Mechanism: Interaction with serotoninogenic neurons in the CNS.
Street Names: Ecstasy, Molly, Adam.
Treatment for Overdose: Symptomatic treatment.
Street Names: "Acid" and "Microdot".
Dependence: Psychic dependence with no physical withdrawal syndrome; tolerance develops briefly.
Effects: Commonly referred to as a 'trip'. Symptoms include:
Altered sensory perceptions (e.g., seeing sounds and hearing colors)
Hallucinations and illusions
Floating sensations
Flashbacks: Recurrence of drug effects long after use.
Treatment: Anxiolytics for anxiety.
Types:
Solvents: Paint thinners, gasoline, glue, toluene, petrol, kerosene, acetone.
Gases: Butane, propane, refrigerant gases, ether, chloroform, halothane.
Nitrites: Cyclohexyl nitrite, amyl nitrite.
Acute Symptoms: Produce stimulatory effects such as euphoria and enhanced musical appreciation; overdoses can cause:
Syncope
Suffocation
Cardiac failure and death.
Characteristics: Active ingredient in cigarettes; causes dependence, tolerance, and withdrawal symptoms.
Nicotine affects cholinergic receptors.
Increases release of acetylcholine, serotonin, and beta-endorphins.
Treatment Options:
Nicotine Replacement Therapy:
Gum
Spray
Others
Medications:
Bupropion
Clonidine
Signs of Wasting
Froth at the Nostrils
Enlargement of Regional Lymph Nodes
Body Markings:
Tattoos covering scars.
Linear needle track scars (often pigmented).
Punctate areas of black discoloration from carbonaceous material ("turkey skin").
Multiple skin infections leading to atrophic scars ("tissue paper scars").
Abscesses on Body
Edema of Upper Limbs due to thrombophlebitis.
Nasal Septal Perforation in habitual cocaine users.
Congestion, edema of lungs, bronchopneumonia.
Pleural and pericardial effusion.
Fatty changes and portal hepatic triaditis.
Splenomegaly.
Brain edema and necrosis involving globus pallidus and hippocampus.
Personal Factors:
Physical and mental illness.
Stressful life events.
Failure to achieve goals.
Social and Environmental Factors:
Living and working environment.
Peer influence and availability of drugs.
Common misuse among healthcare professionals.
Drug Factors:
Some drugs cause significant dependence (both physical and psychological).
Examples: LSD causes psychological dependence comparable to physically addictive drugs.
Tolerance:
Users may develop tolerance requiring increased doses to achieve effects.
Mass education via media about the social menace of drug abuse.
Establishment of de-addiction centers by government and NGOs.
Effective treatment and rehabilitation programs.
Implementation of stringent laws against drug trafficking.
Law administration should be free from influence.
Body Packers:
Smugglers ingest drug-filled balloons or condoms.
Typically carry cocaine or brown sugar.
Use constipating agents (e.g., Lomotil) to avoid bowel movements during transport.
Body Pushers:
Insert drug packets into vagina or rectum.
Some keep drugs in cheek pouches.
Body Stuffers: Individuals who hastily swallow drug packets to avoid detection. This practice poses risks due to the packets not being designed for gastrointestinal transport, increasing the likelihood of rupture.
Rupture of Packets: Toxicity becomes evident when packets rupture, potentially leading to poisoning or death (known as body packer syndrome).
Autopsy Findings: Body packers will have several carefully packed bags of drugs, while body stuffers typically have only two or three.
X-ray: May reveal plastic drug packets; however, results are not always definitive.
CT Scan with Contrast: More effective in identifying the presence of drug packets.
Bedside Ultrasound: A non-invasive technique for quickly assessing multiple drug packets, especially in the gastric area.
Glucose Saline: Administer as necessary.
Airway Maintenance: Ensure that the airway is clear and functional.
Electrolyte Correction: Address imbalances that may occur.
Symptomatic Treatment: Provide any additional care based on symptoms.
Countries Involved: Myanmar, Thailand, Laos, and parts of southern China.
Characteristics: Known for rampant opium production and drug trafficking.
Geographic Area: Pakistan, Afghanistan, and Iran.
Opium Production: Responsible for approximately 90% of the world's opium production and illegal trade.
Specific Areas: Varanasi, Lucknow, Bareilly, Barabanki, and Badawan (in UP) and parts of Rajasthan.